| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.01. | ANSELL LIMITED: Becoming a substantial holder | 1 | ASX | ||
| ANSELL LIMITED ADR Aktie jetzt für 0€ handeln | |||||
| 12.01. | ANSELL LIMITED: Appointment of Non-executive Director | 1 | ASX | ||
| 11.01. | ANSELL LIMITED: Notice of FY26 Half Year Results Announcement | - | ASX | ||
| 08.01. | Ansell shares tumble to a 3-month low. Is this a buying opportunity? | 3 | The Motley Fool Australia | ||
| 08.01. | Why Ansell, Elsight, Ramelius, and SGH shares are falling today | 3 | The Motley Fool Australia | ||
| 08.01. | Hot Stocks: Ramelius Resources, Black Cat Syndicate, Ansell | 3 | Finance News Network | ||
| 07.01. | Ansell announces CEO transition: Nathalie Ahlström to succeed Neil Salmon in 2026 | 1 | The Motley Fool Australia | ||
| 07.01. | ANSELL LIMITED: Ansell announces CEO to retire, new CEO appointed | - | ASX | ||
| 23.12.25 | ANSELL LIMITED: Notification of cessation of securities - ANN | - | ASX | ||
| 21.12.25 | ANSELL LIMITED: Update - Notification of buy-back - ANN | 1 | ASX | ||
| 17.12.25 | ANSELL LIMITED: Update - Notification of buy-back - ANN | - | ASX | ||
| 16.12.25 | ANSELL LIMITED: Update - Notification of buy-back - ANN | - | ASX | ||
| 15.12.25 | ANSELL LIMITED: Update - Notification of buy-back - ANN | - | ASX | ||
| 14.12.25 | ANSELL LIMITED: Update - Notification of buy-back - ANN | - | ASX | ||
| 11.12.25 | ANSELL LIMITED: Update - Notification of buy-back - ANN | - | ASX | ||
| 09.12.25 | ANSELL LIMITED: Update - Notification of buy-back - ANN | - | ASX | ||
| 08.12.25 | ANSELL LIMITED: Update - Notification of buy-back - ANN | - | ASX | ||
| 07.12.25 | ANSELL LIMITED: Update - Notification of buy-back - ANN | - | ASX | ||
| 04.12.25 | ANSELL LIMITED: Change in substantial holding | - | ASX | ||
| 04.12.25 | ANSELL LIMITED: Update - Notification of buy-back - ANN | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 43,290 | -0,02 % | BERENBERG stuft Siemens Healthineers auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Siemens Healthineers auf "Buy" mit einem Kursziel von 54 Euro belassen. 2025 sei ein weiteres durchwachsenes Jahr für den... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,200 | -0,05 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für FMC mit einem Kursziel von 37,40 Euro auf "Underweight" belassen. Analyst David Adlington nahm am Donnerstagabend in seinem... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 28,780 | +1,48 % | EQS-Adhoc: Carl Zeiss Meditec AG: Q1 GJ 2025/26 Ergebnis deutlich unter Vorjahr - Prognose für GJ 2025/26 wird voraussichtlich nicht erreicht | EQS-Ad-hoc: Carl Zeiss Meditec AG / Schlagwort(e): Quartalsergebnis/Prognoseänderung
Carl Zeiss Meditec AG: Q1 GJ 2025/26 Ergebnis deutlich unter Vorjahr - Prognose für GJ 2025/26... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 40,090 | +1,14 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,100 | 0,00 % | Privia Health Group, Inc.: Privia Health to Report Fourth Quarter 2025 Results on Thursday, February 26 | ||
| FRESENIUS | 47,990 | -0,79 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
26.01.2026 /... ► Artikel lesen | |
| GENEDX | 104,88 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 29,610 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 23,810 | 0,00 % | ALHC Stock Surges 400%-Here's Why the Bulls Aren't Done | ||
| PROGYNY | 24,825 | 0,00 % | Forecasting The Future: 6 Analyst Projections For Progyny | ||
| LIFESTANCE HEALTH GROUP | 7,310 | -0,41 % | Analysts Turn More Bullish on LifeStance Health Group (LFST) After Dual Price Target Hikes | ||
| MOVANO | 19,540 | 0,00 % | Morning Market Movers: Movano, Direct Digital Holdings, Ryvyl, Erayak Power Solution See Big Swings | SANTA CLARA (dpa-AFX) - At 7:40 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BETA BIONICS | 15,460 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary... ► Artikel lesen | |
| GERRESHEIMER | 26,940 | -0,59 % | Gerresheimer-Aktie // Boden scheint gefunden | Eine beeindruckende Talfahrt erlebte die Gerresheimer-Aktie in den vergangenen Jahren. Nachdem im Herbst 2023 bei 122,90 Euro noch ein Rekordhoch erreicht worden war, ging es bis auf ein Zwischentief... ► Artikel lesen | |
| CERIBELL | 22,070 | -1,08 % | Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution | SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen |